For some time, genetic testing has been predictive and prognostic. It is now assuming a therapeutic role as well. An example is the targeting of breast cancer patients with BRCA mutations for treatment with PARP inhibitors.
Danielle N. Sin, MS
Advertisement
Articles by Danielle N. Sin, MS
Advertisement
Latest Updated Articles
- Clinical Hereditary Cancer Syndromes and Gene Panel Testing
Published: October 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
2
Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment
3
How Do GLP-1 Agents Factor Into Neuroendocrine Tumor Care Strategies?
4
Searching for Synergy in Liver-Dominant Neuroendocrine Tumors
5
